ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID‑19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
Zarychanski, Ryan |
University of Manitoba | Operating Grant | $3,573,336
CIHR Manitoba 2020
Read More